axelvento
9 minutes ago
Anixa Biosciences CEO Provides Letter to Shareholders
With $20 million in cash and investments, we have a cash runway of over 2.5 years. Our clean capital structure—free of warrants, preferred stock, and debt—positions us well to execute our plans and remain agile in a dynamic environ